Aberrant E-cadherin, β-catenin, and glial fibrillary acidic protein (GFAP) expression in canine choroid plexus tumors

Alice Nentwig, Robert Higgins, Thierry Francey, Marcus Doherr, Andreas Zurbriggen, Anna Oevermann

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Expression of E-cadherin and β-catenin has been widely studied in various human and canine epithelial tumors and has been correlated with dedifferentiation, invasiveness, and metastasis. Choroid plexus tumors (CPTs) are of epithelial origin, and the most important prognostic factor in human medicine is the tumor grade. Limited information is available regarding E-cadherin and β-catenin expression in human CPTs, and no information is found in the veterinary literature. In the current study, 42 canine CPTs (19 choroid plexus papillomas and 23 choroid plexus carcinomas) were retrospectively reviewed, and the intensity and cellular staining pattern of E-cadherin and β-catenin were correlated with histological features, paying special attention to grade, invasion, and metastasis. In addition, cytokeratin and glial fibrillary acidic protein (GFAP) antibodies were evaluated as markers for canine CPTs. It was found that loss of E-cadherin and β-catenin expression was uncommon in canine CPTs. Rather, membranous expression of both molecules was increased in CPTs compared to normal choroid plexus (NCP), regardless of tumor grade. Additionally, aberrant cytoplasmic or nuclear expression of both E-cadherin and β-catenin was often observed in CPTs. GFAP was frequently expressed in CPTs in contrast to NCP. None of these parameters were correlated with malignancy, and therefore, do not appear to be useful for prognostic information. Nevertheless, a panel of antibodies including E-cadherin and GFAP might be useful to support the diagnosis of CPTs and help to differentiate them from other tumors, such as ependymomas and metastatic epithelial tumors.

Original languageEnglish (US)
Pages (from-to)14-22
Number of pages9
JournalJournal of Veterinary Diagnostic Investigation
Volume24
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Choroid Plexus Neoplasms
choroid plexus
Catenins
cadherins
Glial Fibrillary Acidic Protein
neuroglia
Cadherins
Canidae
protein synthesis
neoplasms
dogs
Choroid Plexus Papilloma
Neoplasms
Neoplasm Metastasis
metastasis
Ependymoma
Choroid Plexus
Antibodies
Keratins
papilloma

Keywords

  • β-catenin
  • canine
  • choroid plexus tumor
  • cytokeratin
  • E-cadherin
  • glial fibrillary acidic protein

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Aberrant E-cadherin, β-catenin, and glial fibrillary acidic protein (GFAP) expression in canine choroid plexus tumors. / Nentwig, Alice; Higgins, Robert; Francey, Thierry; Doherr, Marcus; Zurbriggen, Andreas; Oevermann, Anna.

In: Journal of Veterinary Diagnostic Investigation, Vol. 24, No. 1, 01.01.2012, p. 14-22.

Research output: Contribution to journalReview article

Nentwig, Alice ; Higgins, Robert ; Francey, Thierry ; Doherr, Marcus ; Zurbriggen, Andreas ; Oevermann, Anna. / Aberrant E-cadherin, β-catenin, and glial fibrillary acidic protein (GFAP) expression in canine choroid plexus tumors. In: Journal of Veterinary Diagnostic Investigation. 2012 ; Vol. 24, No. 1. pp. 14-22.
@article{bbe42b8a500d416f823eb621ab9ea641,
title = "Aberrant E-cadherin, β-catenin, and glial fibrillary acidic protein (GFAP) expression in canine choroid plexus tumors",
abstract = "Expression of E-cadherin and β-catenin has been widely studied in various human and canine epithelial tumors and has been correlated with dedifferentiation, invasiveness, and metastasis. Choroid plexus tumors (CPTs) are of epithelial origin, and the most important prognostic factor in human medicine is the tumor grade. Limited information is available regarding E-cadherin and β-catenin expression in human CPTs, and no information is found in the veterinary literature. In the current study, 42 canine CPTs (19 choroid plexus papillomas and 23 choroid plexus carcinomas) were retrospectively reviewed, and the intensity and cellular staining pattern of E-cadherin and β-catenin were correlated with histological features, paying special attention to grade, invasion, and metastasis. In addition, cytokeratin and glial fibrillary acidic protein (GFAP) antibodies were evaluated as markers for canine CPTs. It was found that loss of E-cadherin and β-catenin expression was uncommon in canine CPTs. Rather, membranous expression of both molecules was increased in CPTs compared to normal choroid plexus (NCP), regardless of tumor grade. Additionally, aberrant cytoplasmic or nuclear expression of both E-cadherin and β-catenin was often observed in CPTs. GFAP was frequently expressed in CPTs in contrast to NCP. None of these parameters were correlated with malignancy, and therefore, do not appear to be useful for prognostic information. Nevertheless, a panel of antibodies including E-cadherin and GFAP might be useful to support the diagnosis of CPTs and help to differentiate them from other tumors, such as ependymomas and metastatic epithelial tumors.",
keywords = "β-catenin, canine, choroid plexus tumor, cytokeratin, E-cadherin, glial fibrillary acidic protein",
author = "Alice Nentwig and Robert Higgins and Thierry Francey and Marcus Doherr and Andreas Zurbriggen and Anna Oevermann",
year = "2012",
month = "1",
day = "1",
doi = "10.1177/1040638711425940",
language = "English (US)",
volume = "24",
pages = "14--22",
journal = "Journal of Veterinary Diagnostic Investigation",
issn = "1040-6387",
publisher = "American Association of Veterinary Laboratory Diagnosticians",
number = "1",

}

TY - JOUR

T1 - Aberrant E-cadherin, β-catenin, and glial fibrillary acidic protein (GFAP) expression in canine choroid plexus tumors

AU - Nentwig, Alice

AU - Higgins, Robert

AU - Francey, Thierry

AU - Doherr, Marcus

AU - Zurbriggen, Andreas

AU - Oevermann, Anna

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Expression of E-cadherin and β-catenin has been widely studied in various human and canine epithelial tumors and has been correlated with dedifferentiation, invasiveness, and metastasis. Choroid plexus tumors (CPTs) are of epithelial origin, and the most important prognostic factor in human medicine is the tumor grade. Limited information is available regarding E-cadherin and β-catenin expression in human CPTs, and no information is found in the veterinary literature. In the current study, 42 canine CPTs (19 choroid plexus papillomas and 23 choroid plexus carcinomas) were retrospectively reviewed, and the intensity and cellular staining pattern of E-cadherin and β-catenin were correlated with histological features, paying special attention to grade, invasion, and metastasis. In addition, cytokeratin and glial fibrillary acidic protein (GFAP) antibodies were evaluated as markers for canine CPTs. It was found that loss of E-cadherin and β-catenin expression was uncommon in canine CPTs. Rather, membranous expression of both molecules was increased in CPTs compared to normal choroid plexus (NCP), regardless of tumor grade. Additionally, aberrant cytoplasmic or nuclear expression of both E-cadherin and β-catenin was often observed in CPTs. GFAP was frequently expressed in CPTs in contrast to NCP. None of these parameters were correlated with malignancy, and therefore, do not appear to be useful for prognostic information. Nevertheless, a panel of antibodies including E-cadherin and GFAP might be useful to support the diagnosis of CPTs and help to differentiate them from other tumors, such as ependymomas and metastatic epithelial tumors.

AB - Expression of E-cadherin and β-catenin has been widely studied in various human and canine epithelial tumors and has been correlated with dedifferentiation, invasiveness, and metastasis. Choroid plexus tumors (CPTs) are of epithelial origin, and the most important prognostic factor in human medicine is the tumor grade. Limited information is available regarding E-cadherin and β-catenin expression in human CPTs, and no information is found in the veterinary literature. In the current study, 42 canine CPTs (19 choroid plexus papillomas and 23 choroid plexus carcinomas) were retrospectively reviewed, and the intensity and cellular staining pattern of E-cadherin and β-catenin were correlated with histological features, paying special attention to grade, invasion, and metastasis. In addition, cytokeratin and glial fibrillary acidic protein (GFAP) antibodies were evaluated as markers for canine CPTs. It was found that loss of E-cadherin and β-catenin expression was uncommon in canine CPTs. Rather, membranous expression of both molecules was increased in CPTs compared to normal choroid plexus (NCP), regardless of tumor grade. Additionally, aberrant cytoplasmic or nuclear expression of both E-cadherin and β-catenin was often observed in CPTs. GFAP was frequently expressed in CPTs in contrast to NCP. None of these parameters were correlated with malignancy, and therefore, do not appear to be useful for prognostic information. Nevertheless, a panel of antibodies including E-cadherin and GFAP might be useful to support the diagnosis of CPTs and help to differentiate them from other tumors, such as ependymomas and metastatic epithelial tumors.

KW - β-catenin

KW - canine

KW - choroid plexus tumor

KW - cytokeratin

KW - E-cadherin

KW - glial fibrillary acidic protein

UR - http://www.scopus.com/inward/record.url?scp=84857311384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857311384&partnerID=8YFLogxK

U2 - 10.1177/1040638711425940

DO - 10.1177/1040638711425940

M3 - Review article

VL - 24

SP - 14

EP - 22

JO - Journal of Veterinary Diagnostic Investigation

JF - Journal of Veterinary Diagnostic Investigation

SN - 1040-6387

IS - 1

ER -